TY -的T1 -远程缺血与新颖的光学传感器的反馈调节装置在急性缺血性中风——那就是很可行性研究(赛0 - 5.002)JF -神经学乔-神经学做- 10.1212 / WNL。首页0000000000203749六世- 100 - 17补充2 SP - 4111 AU -罗伯特·约瑟夫188金宝慱官网下载Sarmiento盟完婚Nair AU -阿什法克Shuaib AU -布莱恩·巴克盟-米歇尔Gauthier盟维维安Mushahwar AU -马丁Ferguson-Pell盟Mahesh凯特Y1 - 2023/04/25 UR - //www.ez-admanager.com/content/100/17_Supplement_2/4111.abstract N2 -目的:检查的可行性小说远程缺血首页条件(RIC)设备。背景:里克疗法是通过增加压力的装备最多50毫米汞柱以上收缩压200毫米汞柱。这可能是与不适,因此减少遵守RIC疗法。我们小组已经开发了一个新的RIC设备,光学传感器评估皮肤灌注远端肢体缺血期间RIC疗法。设计/方法:这是一个前瞻性单中心随机对照试验,该装置的可行性。急性缺血性中风患者的中度至重度小血管疾病随机2:1干预和虚假的控制武器的7天或者直到放电。所有患者随机分配到干预组将获得5周期non-paralyzed缺血/再灌注的手臂。病人在虚假的控制杆将获得30毫米汞柱压力的感觉,将袖口的压力保持在5分钟5周期。结果:我们有了总共10(7干预手臂和3虚假的控制)病人日期在一个值(差)71.5(79.5)小时后出现症状,与平均数±标准差68.6±9岁,中位数(差)署5 (8)。我们没有发现不同的氧合血红蛋白和血红蛋白浓度与30或50毫米汞柱的收缩压增加手臂袖口干预组。手术安慰李克特量表的测量显示值(差)为3.00(1,既不舒适也不舒服)干预的胳膊,1.50(1,很舒服)虚假的控制杆。 No safety concerns were noted in the intervention or sham arm.Conclusions: RIC with the skin perfusion sensor assessment is feasible. There were no safety concerns.Clinical Trial Registration Number: clinicaltrials.gov NCT05408130Disclosure: Dr. Sarmiento has nothing to disclose. Dr. Nair has nothing to disclose. Dr. Shuaib has nothing to disclose. Dr. Buck has nothing to disclose. Mr. Gauthier has nothing to disclose. The institution of Prof. Mushahwar has received research support from University Hospital Foundation. Dr. Ferguson-Pell has stock in Click&Push Inc.. Dr. Ferguson-Pell has stock in Moshion Inc.. Dr. Kate has nothing to disclose. ER -